Daily non-political popular news in brief.

IMS updated recommendations on postmenopausal hormone therapy

The Updated Recommendations express the views of the International Menopause Society on the principles of hormone therapy in the peri- and postmenopausal periods. New data and re-analyses of older studies by women's age show that, for most women, the potential benefits of hormone therapy given for a clear indication are many and the risks are few when initiated within a few years of menopause.

Read more »

Keywords: ims, updated, recommendations, postmenopausal, hormone, therapy, recommendation

« Previous | Next »

Similar news on "IMS updated recommendations on postmenopausal hormone therapy":

1. IMS reaction to report on breast cancer incidence in 2003 in US
   04-18-2007 · EurekAlert!
   Following a report of the analysis of data from the SEER registries of the NCI, showing that the incidence of breast cancer fell by 6.7 percent in 2003 in the US, and the suggestion that the data might be linked to the decrease in the use of postmenopausal hormones, the IMS advises caution in linking these two trends and recommends that hormone therapy be prescribed whenever indicated.
   Similar news · Read more »
   
2. Estrogen therapy in younger postmenopausal women linked to less plaque in arteries
   06-20-2007 · EurekAlert!
   New results from a substudy of the Women's Health Initiative (WHI) Estrogen-Alone Trial show that younger postmenopausal women who take estrogen-alone hormone therapy have significantly less buildup of calcium plaque in their arteries compared to their peers who did not take hormone therapy.
   Similar news · Read more »
   
3. Postmenopausal hormone therapy and coronary disease -- the truth of the matter
   06-20-2007 · EurekAlert!
   The results of WHI-CACS, now published in New England Journal of Medicine are very encouraging, since women who were randomized to the estrogen arm of the WHI had significantly smaller calcification scores than counterparts in the placebo arm. This study reaffirms that estrogen has a wide range of well-documented beneficial metabolic and vascular effects, provided that treatment is started early in menopause. Women can be reassured that estrogen therapy is cardioprotective at least until age 65.
   Similar news · Read more »
   
4. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
   01-15-2008 · EurekAlert!
   Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
   Similar news · Read more »
   
5. Hormone replacement therapy may improve trip down memory lane
   11-16-2006 · EurekAlert!
   Research from the University of Michigan Health System suggests that hormone therapy might help women retain certain memory functions. In a study in the new issue of the Journal of Clinical Endocrinology & Metabolism, they report that a group of postmenopausal women showed more brain activity during a visual memory test than did women who were not taking the hormone therapy.
   Similar news · Read more »
   
6. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
   09-18-2007 · EurekAlert!
   Despite the huge publicity generated by a 2002 study on the potential dangers of hormone therapy for postmenopausal women, new research from the Stanford University School of Medicine found that only 29 percent of women surveyed knew about the study two years later.
   Similar news · Read more »
   
7. Weight gain related to postmenopausal breast cancer risk
   10-22-2007 · EurekAlert!
   Women who gain weight throughout adulthood rather than maintaining a stable weight may have an increased risk for breast cancer, according to a report in the Oct. 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This finding was observed among women who did not take hormone therapy after menopause.
   Similar news · Read more »
   
8. Decrease in breast cancer incidence linked to drop in hormone replacement
   04-18-2007 · EurekAlert!
   A special report in the April 19, 2007, edition of the New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative and the ensuing drop in hormone-replacement therapy among postmenopausal women.
   Similar news · Read more »
   
9. Breast cancer and hormone therapy -- A looking-glass mirror?
   07-24-2007 · EurekAlert!
   A new study raises the issue of a direct link between breast cancer incidence and use of postmenopausal hormone therapy (HT). Breast cancer incidence and mammography screening rates during 1980-2006 showed similar but not synchronous periodic fluctuations. The implication that HT use equates to the risk of breast cancer is therefore too simplistic and inappropriate.
   Similar news · Read more »
   
10. Hormone drug type makes survival difference in advanced breast cancer
    01-30-2007 · EurekAlert!
    Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.
    Similar news · Read more »